Harout Semerjian
Chief Executive Officer presso GLYCOMIMETICS, INC.
Patrimonio netto: 75 000 $ in data 31/03/2024
Profilo
Harout Semerjian is the President, Chief Executive Officer & Director at GlycoMimetics, Inc. He was previously the President, Chief Executive Officer & Director at Immunomedics, Inc. for a brief period in 2020.
Before that, he was the Chief Commercial Officer & Executive VP at Ipsen SA from 2018 to 2020 and the Managing Director at Ipsen Pharma SAS.
Semerjian holds an MBA from both Queen's University and Cornell University, as well as an undergraduate degree from Lebanese American University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
GLYCOMIMETICS, INC.
0.04% | 15/03/2024 | 25 000 ( 0.04% ) | 75 000 $ | 31/03/2024 |
Posizioni attive di Harout Semerjian
| Società | Posizione | Inizio |
|---|---|---|
| GLYCOMIMETICS, INC. | Chief Executive Officer | 06/08/2021 |
Precedenti posizioni note di Harout Semerjian
| Società | Posizione | Fine |
|---|---|---|
| IMMUNOMEDICS, INC. | Chief Executive Officer | 27/05/2020 |
| IPSEN | Corporate Officer/Principal | 01/04/2020 |
Ipsen Pharma SAS
 Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Ipsen Pharma SAS is a biopharmaceutical company that develops medicines in oncology, neuroscience and rare diseases. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France. | Corporate Officer/Principal | - |
Formazione di Harout Semerjian
| Queen's University | Masters Business Admin |
| Cornell University | Masters Business Admin |
| Lebanese American University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| IPSEN | Health Technology |
| GLYCOMIMETICS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Immunomedics, Inc. researching, developing, manufacturing, and marketing biopharmaceutical products. It focuses on monoclonal antibody-based products for the targeted treatment of cancer. The company was founded by David M. Goldenberg in July 1982 and is headquartered in Morris Plains, NJ. | Health Technology |
Ipsen Pharma SAS
Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Ipsen Pharma SAS is a biopharmaceutical company that develops medicines in oncology, neuroscience and rare diseases. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France. | Health Technology |
- Borsa valori
- Insiders
- Harout Semerjian
